Background CoV2 preS dTM is a stabilised pre-fusion spike protein vaccine produced in a
baculovirus expression system being developed against SARS-CoV-2. We present interim …

Background We evaluated our SARS-CoV-2 prefusion spike recombinant protein vaccine (CoV2
preS dTM) with different adjuvants, unadjuvanted, and in a one-injection and two-…

Background The 2014 Zaire Ebola virus outbreak highlighted the need for a safe, effective
vaccine with a rapid onset of protection. We report the safety and immunogenicity of the …

Background Children with cow's milk allergy ( CMA ) are at risk for inadequate nutritional
intake and growth. Dietary management of CMA , therefore, requires diets that are not only …

Background Prevention of respiratory syncytial virus (RSV) disease in infants is an unmet
vaccine need, and maternal immunization is a potential strategy to address this need. This …

Background Human metapneumovirus (hMPV) and parainfluenza virus type 3 (PIV3) cause
respiratory tract illness in children and the elderly. No licensed vaccines are available. …

OBJECTIVE Young children are at increased risk for influenza-related complications. Safety
and immunogenicity of a cell-based quadrivalent inactivated influenza vaccine (QIVc) was …

Background This study evaluated the safety and immunogenicity of an AS03-adjuvanted
SARS-CoV-2 recombinant protein candidate vaccine, CoV2 preS dTM. Methods This Phase 2, …

Background Effective vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
are urgently needed. CoV2 preS dTM is a stabilised pre-fusion S protein …

Pre-and probiotics (synbiotics) are suggested to have beneficial effects on human health.
This study describes effects of an amino acid based formula (AAF) with synbiotics in infants …